Skip to content

Shockwave IVL System with the Shockwave S4 Peripheral IVL Catheter S4IVLK2540Recalls & reported problems

Shockwave Medical, Inc. · The Shockwave S4 Intravascular Lithotripsy (IVL) Catheter consists of an array of miniaturized lithotripsy emitters, located inside a balloon, that generate acoustic pressure waves within the target treatment site, disrupting calcium within the lesion and allowing subsequent dilation of a peripheral artery stenosis using low balloon pressure. Two radiopaque marker bands inside the balloon aid in positioning. The distal catheter and balloon are hydrophilic coated to increase lubricity. The proximal hub has three ports: one for inflation/deflation of the balloon with 50/50 saline/contrast medium, one for the ‘Over-the-wire’ (OTW) guidewire lumen, and one for connection to the IVL Connector Cable (and IVL Generator). · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00195451000317), received between Jul 3, 2024 and Jul 3, 2024 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 1 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Ischemia1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryJul 3, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A SHOCKWAVE S4 PERIPHERAL INTRAVASCULAR LITHOTRIPSY (IVL) CATHETER WAS USED TO TREAT A LESION IN THE LEFT PERONEAL ARTERIES FOR THE BTK II CLINICAL STUDY. THE SUBJECT WAS ADMITTED WITH NECROTIC, ISCHEMIC, MUMMIFIED TOES TO THE LEFT FOOT. THE IVL CATHETER SUCCESSFULLY DELIVERED 160 PULSES TO TREAT THE LESION AND THERE WAS NO DEVICE MALFUNCTION REPORTED. THE PATIENT WAS THEN ADMITTED 4 DAYS POST INDEX PROCEDURE FOR A LEFT TRANS-METATARSAL AMPUTATION (TMA) WHICH WAS PERFORMED WITHOUT ANY ISSUE. THE PATIENT WAS THEN DISCHARGED A FEW DAYS LATER WITH NO EVIDENCE OF ANY ADVERSE EVENTS AT DISCHARGE. 11 DAYS AFTER THE INDEX PROCEDURE, THE PATIENT WAS ADMITTED FOR WOUND DEHISCENCE RELATING TO THE TMA. AN INTERVENTION WAS PERFORMED WHERE WOUND DEBRIDEMENT WAS PERFORMED, AND A WOUND VACUUM WAS USED TO TREAT THE WOUND DEHISCENCE. MEDICATIONS AND OCCUPATIONAL THERAPY WERE PRESCRIBED. THE SITE REPORTED THESE EVENTS AS UNRELATED TO THE IVL DEVICE AND PROCEDURE. 3 MONTHS AFTER THE INDEX PROCEDURE, THE PATIENT DEVELOPED RIGHT LEG PERIPHERAL VASCULAR DISEASE (PVD) WITH A PLANNED RIGHT LOWER EXTREMITY INTERVENTION. 6 MONTHS AFTER THE INDEX PROCEDURE, THE PATIENT WAS ADMITTED WITH ISCHEMIA AND REQUIRED

    Patient problems: Ischemia

    MAUDE report 19671909 ↗

Other Cardiovascular Procedure Kit devices

All Cardiovascular Procedure Kit devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page